[144] Cigna Group SEC Filing

Rhea-AI Filing Summary

Cigna Group (CI) filed a Form 144 disclosing a proposed sale of 5,368 common shares through Fidelity Brokerage Services LLC on 10/03/2025. The filing lists an aggregate market value of $1,610,400 and 266,928,075 shares outstanding for the issuer. The shares were acquired under an option granted on 03/01/2016 and are shown as acquired on 10/03/2025, with payment noted as cash. The filer certifies no undisclosed material adverse information and indicates no securities sold in the prior three months.

Positive

• Regulatory compliance: Form 144 filed, disclosing the proposed sale openly
• No prior sales in past three months: filing states "Nothing to Report" for recent sales

Negative

• Insider sale planned: proposed disposition of 5,368 shares valued at $1,610,400
• Concentration vs. outstanding shares: sale represents a small insider liquidation relative to 266,928,075 outstanding shares

Insights

Insider Transactions Analyst

TL;DR: Insider plans to sell 5,368 shares worth $1.61M on 10/03/2025.

The filing shows a proposed sale executed through Fidelity Brokerage Services LLC with an aggregate market value of $1,610,400. The shares were acquired via an option granted on 03/01/2016 and recorded as acquired on 10/03/2025, with payment in cash.

This notice is a regulatory disclosure under Rule 144 and contains the filer's representation that no material nonpublic information is known; the filing also reports no sales in the past three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5368	1610400.00	266928075	10/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/03/2025	Option Granted 03/01/2016	Issuer			5368	10/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cigna's (CI) Form 144 disclose?

It discloses a proposed sale of 5,368 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $1,610,400 dated 10/03/2025.

When is the planned sale of CI shares scheduled?

The approximate date of sale listed on the Form 144 is 10/03/2025.

How were the shares being sold by CI acquired?

The shares were acquired via an option granted on 03/01/2016 and are listed as acquired on 10/03/2025, with payment in cash.

Does the filing report recent insider sales for CI?

No. The "Securities Sold During The Past 3 Months" section states Nothing to Report.

Through which broker will the CI shares be sold?

The broker named is Fidelity Brokerage Services LLC (address listed in the filing).